(Q36659957)

15 August 2017

1 reference

title

Emerging therapies in the treatment of Clostridium difficile-associated disease (English)

1 reference

15 August 2017

main subject

Clostridium difficile

0 references

author name string

Tomasz Z Jodlowski

1

1 reference

15 August 2017

Richard Oehler

2

1 reference

15 August 2017

Linda W Kam

3

1 reference

15 August 2017

Igor Melnychuk

4

1 reference

15 August 2017

language of work or name

English

0 references

publication date

21 November 2006

1 reference

Annals of Pharmacotherapy

15 August 2017

published in

1 reference

15 August 2017

volume

40

1 reference

15 August 2017

issue

12

1 reference

15 August 2017

page(s)

2164-2169

1 reference

Clostridium difficile-associated diarrhea in adults

15 August 2017

cites work

1 reference

Clostridium difficile-associated disease: an emerging threat to patient safety: insights from the Society of Infectious Diseases Pharmacists

21 January 2018

1 reference

Treatment of Clostridium difficile-associated disease: old therapies and new strategies

21 January 2018

1 reference

Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies

21 January 2018

1 reference

Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

21 January 2018

1 reference

Treatment of Clostridium difficile-associated diarrhea

21 January 2018

1 reference

Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use.

21 January 2018

1 reference

An epidemic, toxin gene-variant strain of Clostridium difficile

21 January 2018

1 reference

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

21 January 2018

1 reference

Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole

21 January 2018

1 reference

Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections

21 January 2018

1 reference

Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential

21 January 2018

1 reference

Nitazoxanide: a new thiazolide antiparasitic agent

21 January 2018

1 reference

In vitro and in vivo activities of nitazoxanide against Clostridium difficile

21 January 2018

1 reference

Nitazoxanide for the treatment of Clostridium difficile colitis

21 January 2018

1 reference

Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin

21 January 2018

1 reference

Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea

21 January 2018

1 reference

Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea

21 January 2018

1 reference

Intravenous immunoglobulin for resistant Clostridium difficile infection

21 January 2018

1 reference

Tinidazole: a nitroimidazole antiprotozoal agent

21 January 2018

1 reference

Comparative activity of metronidazole and tinidazole against Clostridium difficile and Peptostreptococcus anaerobius

21 January 2018

1 reference

Toxin binding of tolevamer, a polyanionic drug that protects against antibiotic-associated diarrhea

21 January 2018

1 reference

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

21 January 2018

1 reference

In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficile

21 January 2018

1 reference

Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults

21 January 2018

1 reference

Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea

21 January 2018

1 reference

Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1H340

1 reference

15 August 2017

1 reference